Evidence map›Paper›PMID 41174964›Full record

ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2025

Single cell RNA-seq analysis of hematopoietic cell types in 22q11.2 deletion syndrome reveals significant changes to non-T cells.

Katherine Beigel, Nouf Alsaati, Kelly Maurer, Donna McDonald-McGinn, T Blaine Crowley, Montana Knight, Sarah E Henrickson, Anne S Bassett, Kathleen E Sullivan

Abstract read
In one paragraph

Article in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katherine BeigelDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-3439-6042
Nouf AlsaatiDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Kelly MaurerDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Donna McDonald-McGinnDivision of Clinical Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
T Blaine CrowleyDivision of Clinical Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Montana KnightDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-5229-4122
Sarah E HenricksonDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Anne S BassettClinical Genetics Research Program at the Centre for Addiction and Mental Health, and Dalglish Family 22q Clinic, University Health Network, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-0681-7279
Kathleen E SullivanDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Funding

USIDNET: A resource for clinical immunologistsR24AI171055 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI KATHLEEN E SULLIVAN · 2022 to 2026
$7.0M
Dalglish Family Chair in 22q11.2 Deletion Syndrome at the University Health Network and University of TorontoMCHRI Uytengsu-Hamilton 22q11 Neuropsychiatry Research AwardNIAID NIH HHS R24 AI171055The Children's Hospital of Philadelphia
6 · The paper itself

Abstract

background22q11.2 Deletion syndrome is one of the most common inborn errors of immunity. There is a large body of literature supporting alterations to T cells as a result of thymic hypoplasia. Additional studies have supported changes to B cell behavior which have been presumed to be secondary to impaired T cell help. Yet, there remains a significant gap in our understanding of the impact of this syndrome on non-T cells.

methodsThis study utilized a cohort of 46 participants with 22q11.2 deletion syndrome and 18 age and sex-matched controls. 5' single-cell RNAseq was performed to characterize cell populations and altered gene expression.

resultsAll cell types exhibited RNA expression differences between patients and controls. Across T cells, B cells, NK cells and monocytes, there were no conserved modules either up or down regulated; however, all cell types exhibited differences between controls and patients. Among naïve, memory, and terminal effector CD4 T cells, we observed a number of signatures related to proliferation as manifested by translation initiation and ribosomal component gene expression that were increased in patients. Patients who had had cardiac surgery had altered CD8 T cells with lower naïve CD8 T cells compared to patients who did not have cardiac surgery and increased gene expression in modules defined by oxidative phosphorylation and interferon exposure.

conclusionsSurprisingly, all cell types examined exhibited differences between patients and controls. Monocytes and NK cells, the cell types least likely to be directly impacted by thymic effects, had unique patterns of gene expression, although both were highly altered in patients. This suggests a widespread impact of the deletion that may be related to direct and indirect effects of reduced gene dosage.

Indexed as

B-LymphocytesDiGeorge SyndromeKiller Cells, NaturalAdolescentAdultChildChild, PreschoolFemaleHumansInfantMaleRNA-SeqSingle-Cell AnalysisT-LymphocytesDiGeorge syndromeinflammationmonocytesNK cellssingle cell RNA‐seqT cells

Identifiers

PMID41174964
PMCPMC13677007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.